Zacks.com on MSN
AptarGroup (ATR) Q3 Earnings and Revenues Top Estimates
AptarGroup (ATR) delivered earnings and revenue surprises of +3.18% and +0.91%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?
While the top- and bottom-line numbers for AptarGroup (ATR) give a sense of how the business performed in the quarter ended September 2025, it could be worth looking at how some of its key metrics ...
Investor's Business Daily on MSN
Here's Why We Exited Walmart Stock Before It Hit Its Stop
Once we recognized our position in Walmart wasn't working, we exited early to make the trade flat instead of waiting for ...
Privia Health Group, Inc. offers high-growth potential with recurring revenue model and strong relationships. Learn more ...
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest news and ...
Investor's Business Daily on MSN
After More Than Tripling, Energy Drink Maker Celsius Hits Latest Buy Point. But Earnings Loom.
Celsius stock hit its latest buy point before retreating. And third-quarter earnings results are due out in early November.
6hon MSN
AptarGroup outlines 35% decline in emergency medicine revenue for 2026 amid shifting pharma demand
Get key insights from AptarGroup’s Q3 2025 earnings call—injectables growth, Brazil expansion, and 2026 margin headwinds. See what’s next for ATR.
AptarGroup Inc (ATR) reports a 6% sales growth and a dividend increase, while addressing challenges in its beauty and consumer healthcare segments.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback